Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL. 70, 2012, Pages

  Kostianovsky, Alex ^a,e   Hauser, Thomas ^a,f   Pagnoux, Thomas ^a   Cohen, Pascal ^a   Daugas, Eric ^b   Mouthon, Luc ^a   Miossec, Pierre ^c   Cordier, Jean François ^d   Guillevin, Loïc ^a   Bachmeyer, Claude ^g   Barbier, Stéphane ^h   Belmatoug, Nadia ⁱ   Bielefeld, Philip ^j   Bouredji, Daoud ^g   Bourgarit, Anne ^k   Bruet, Alain ^l   Cadranel, Jacques ⁱ   Chazerain, Pascal ⁱ   Chinet, Thierry ^m   Coëtmeur, Daniel ⁿ   Cottin, Vincent ^o   Demolombe Rague, Sylvie ^o   Dhôte, Robin ^p   Girault, Anouk ^ah   Fauchais, Anne Laure ^q   Gobert, Pierre ^r   Godeau, Bertrand ^s   Hillion, Daniel ^l   Janin Magnificat, Luc ^t   Kaloustian, Edgar ^u   Kouyoumdjian, Laurence ^v   Kyndt, Xavier ^w   Israël Biet, Dominique ⁱ   de Lassence, Arnaud ^x   Leclerc, Pascal ^y   Le Jeunne, Claire ⁱ   Le Noach, José ^z   Lhote, François ^aa   Lifermann, François ^ab   Lobbedez, Thierry ^ac   Longuet, Olivier ^q   Pastural, Myriam ^s   Plaisier, Emmanuelle ⁱ   Ponge, Thierry ^ad   Rogé, Christophe ^z   Rince, Michel ^q   Rondeau, Eric ⁱ   Rossert, Jérôme ⁱ   Roux, Marielle ^ae   Stern, Marc ^af   Tanter, Yves ^j   Tirot, Patrice ^ag   Valeyre, Dominique ^p   Vanhille, Philippe ^w   Vidal, Elisabeth ^q   Vrtovsnik, François ⁱ   Zoulim, Abdelkader ^ac   more..

^a Université Paris Descartes ^*  (France)

^b BICHAT HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e CEMIC   (Argentina)

^f Immunologie Zentrum Zurich   (Switzerland)

^g French Vasculitis Study Group (FVSG)   (France)

^h French Vasculitis Study Group (FVSG)   (France)

ⁱ French Vasculitis Study Group (FVSG)   (France)

^j French Vasculitis Study Group (FVSG)   (France)

^k French Vasculitis Study Group (FVSG)   (France)

^l French Vasculitis Study Group (FVSG)   (France)

^m French Vasculitis Study Group (FVSG)   (France)

ⁿ French Vasculitis Study Group (FVSG)   (France)

^o French Vasculitis Study Group (FVSG)   (France)

^p French Vasculitis Study Group (FVSG)   (France)

^q French Vasculitis Study Group (FVSG)   (France)

^r French Vasculitis Study Group (FVSG)   (France)

^s French Vasculitis Study Group (FVSG)   (France)

^t French Vasculitis Study Group (FVSG)   (France)

^u French Vasculitis Study Group (FVSG)   (France)

^v French Vasculitis Study Group (FVSG)   (France)

^w French Vasculitis Study Group (FVSG)   (France)

^x French Vasculitis Study Group (FVSG)   (France)

^y French Vasculitis Study Group (FVSG)   (France)

^z French Vasculitis Study Group (FVSG)   (France)

^aa French Vasculitis Study Group (FVSG)   (France)

^ab French Vasculitis Study Group (FVSG)   (France)

^ac French Vasculitis Study Group (FVSG)   (France)

^ad French Vasculitis Study Group (FVSG)   (France)

^ae French Vasculitis Study Group (FVSG)   (France)

^af French Vasculitis Study Group (FVSG)   (France)

^ag French Vasculitis Study Group (FVSG)   (France)

^ah French Vasculitis Study Group (FVSG)   (France)

more..

Author keywords

Alveolar haemorrhage; ANCA; Churg Strauss syndrome; Microscopic polyangiitis; Wegener's granulomatosis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; RITUXIMAB; STEROID;

ADOLESCENT; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; ARTIFICIAL VENTILATION; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; GRANULOMATOSIS; HEMOPTYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUNG BIOPSY; LUNG HEMORRHAGE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RELAPSE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; WEGENER GRANULOMATOSIS; X RAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; DATABASES, FACTUAL; FEMALE; GLOMERULONEPHRITIS; HEMOPTYSIS; HEMORRHAGE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84863751563     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. JENNETTE JC, FALK RJ, ANDRASSY K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
2. SCHWARZ MI, BROWN KK Small vessel vasculitis of the lung. Thorax 2000; 55: 502-10.
3. LEE RW, D'CRUZ DP Pulmonary renal vasculitis syndromes. Autoimmun Rev 2010; 9: 657-60.
4. GALLAGHER H, KWAN JT, JAYNE DR Pulmonary renal syndrome: a 4-year, singlecenter experience. Am J Kidney Dis 2002; 39: 42-7.
5. CHEN YX, ZHANG W, CHEN XN et al. Application of RIFLE criteria in Chinese patients with ANCA-associated renal vasculitis. Clin Exp Rheumatol 2011; 29: 951-7.
6. GUILLEVIN L, PAGNOUX C, SEROR R, MAHR A, MOUTHON L, LE TOUMELIN P The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the FVSG cohort. Medicine (Baltimore) 2011; 90: 19-27.
7. LEAVITT RY, FAUCI AS, BLOCH DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
8. MASI AT, HUNDER GG, LIE JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.
9. GUILLEVIN L, DURAND-GASSELIN B, CEVALLOS R et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421-30.
10. PHILLIP R, LUQMANI R Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S94-S104.
11. NACHMAN PH, HOGAN SL, JENNETTE JC, FALK RJ Treatment response and relapse in antineutrophil cytoplasmic autoantibodyassociated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 33-9.
12. HOGAN SL, FALK RJ, CHIN H et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005; 143: 621-31.
13. MUKHTYAR C, GUILLEVIN L, CID MC et al. FOR THE EUROPEAN VASCULITIS STUDY GROUP: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009; 68: 310-7.
14. GUILLEVIN L, CORDIER JF, LHOTE F et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40: 2187-98.
15. FAUCI AS, HAYNES BF, KATZ P, WOLFF SM Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
16. HOFFMAN GS, KERR GS, LEAVITT RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
17. STONE JH, MERKEL PA, SPIERA R, SEO P, LANGFORD CA, HOFFMAN GS Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363: 221-32.
18. JONES RB, COHEN TERVAERT JW, HAUSER T, LUQMANI R, MORGAN MD Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010; 363: 211-20.
19. LAUQUE D, CADRANEL J, LAZOR R et al. FOR THE GROUPE D'ETUDES ET DE RECHERCHE SUR LES MALADIES «ORPHELINES» PULMONAIRES (GERM»O»P): Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM" O" P). Medicine (Baltimore) 2000; 79: 222-33.
20. ADU D, PALL A, LUQMANI RA et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM 1997; 90: 401-9.
21. HAUBITZ M, SCHELLONG S, GOBEL U et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum 1998; 41: 1835-44.
22. DE GROOT K, RASMUSSEN N, BACON PA et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52: 2461-9.
23. CASIAN A, JAYNE D Management of alveolar hemorrhage in lung vasculitides. Semin Respir Crit Care Med 2011; 32: 335-45.
24. CERDAS-QUESADA C Plasma exchange for Goodpasture syndrome. Transfus Apher Sci 2010; 42: 115-6.
25. JAYNE DR, GASKIN G, RASMUSSEN N et al. AND ON BEHALF OF THE EUROPEAN VASCULITIS STUDY GROUP: Randomized trial of plasmaexchange or high dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18: 2180-8.
26. KLEMMER PJ, CHALERMSKULRAT W, REIF MS, HOGAN SL, HENKE DC, FALK RJ Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003; 42: 1149-53.